Your browser doesn't support javascript.
loading
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.
Angelova-Toshkina, Daniela; Decker, Josua A; Traunwieser, Thomas; Holzapfel, Johannes; Bette, Stefanie; Huber, Simon; Schimmel, Mareike; Vollert, Kurt; Bison, Brigitte; Kröncke, Thomas; Bramswig, Nuria C; Wieczorek, Dagmar; Gnekow, Astrid K; Frühwald, Michael C; Kuhlen, Michaela.
Afiliación
  • Angelova-Toshkina D; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: daniela.angelova-toshkina@uk-augsburg.de.
  • Decker JA; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: josua.decker@uk-augsburg.de.
  • Traunwieser T; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: thomas.traunwieser@uk-augsburg.de.
  • Holzapfel J; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: johannes.holzapfel@uk-augsburg.de.
  • Bette S; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: stefanie.bette@uk-augsburg.de.
  • Huber S; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: simon.huber@uk-augsburg.de.
  • Schimmel M; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: mareike.schimmel@uk-augsburg.de.
  • Vollert K; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: kurt.vollert@uk-augsburg.de.
  • Bison B; Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: brigitte.bison@uk-augsburg.de.
  • Kröncke T; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany. Electronic address: thomas.kroencke@uk-augsburg.de.
  • Bramswig NC; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40255, Düsseldorf, Germany. Electronic address: nuria.braemswig@hhu.de.
  • Wieczorek D; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40255, Düsseldorf, Germany. Electronic address: dagmar.wieczorek@med.uni-duesseldorf.de.
  • Gnekow AK; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: astrid.gnekow@uk-augsburg.de.
  • Frühwald MC; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: michael.fruehwald@uk-augsburg.de.
  • Kuhlen M; Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany. Electronic address: michaela.kuhlen@uk-augsburg.de.
Eur J Paediatr Neurol ; 43: 52-61, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36905830
Neurofibromatosis type 1 (NF1) is a phenotypically heterogenous multisystem cancer predisposition syndrome manifesting in childhood and adolescents. Central nervous system (CNS) manifestations include structural, neurodevelopmental, and neoplastic disease. We aimed to (1) characterize the spectrum of CNS manifestations of NF1 in a paediatric population, (2) explore radiological features in the CNS by image analyses, and (3) correlate genotype with phenotypic expression for those with a genetic diagnosis. We performed a database search in the hospital information system covering the period between January 2017 and December 2020. We evaluated the phenotype by retrospective chart review and imaging analysis. 59 patients were diagnosed with NF1 [median age 10.6 years (range, 1.1-22.6); 31 female] at last follow-up, pathogenic NF1 variants were identified in 26/29. 49/59 patients presented with neurological manifestations including 28 with structural and neurodevelopmental findings, 16 with neurodevelopmental, and 5 with structural findings only. Focal areas of signal intensity (FASI) were identified in 29/39, cerebrovascular anomalies in 4/39. Neurodevelopmental delay was reported in 27/59 patients, learning difficulties in 19/59. Optic pathway gliomas (OPG) were diagnosed in 18/59 patients, 13/59 had low-grade gliomas outside the visual pathways. 12 patients received chemotherapy. Beside the established NF1 microdeletion, neither genotype nor FASI were associated with the neurological phenotype. NF1 was associated with a spectrum of CNS manifestations in at least 83.0% of patients. Regular neuropsychological assessment complementing frequent clinical and ophthalmologic testing for OPG is necessary in the care of each child with NF1.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neurofibromatosis 1 / Glioma del Nervio Óptico Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Eur J Paediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neurofibromatosis 1 / Glioma del Nervio Óptico Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Eur J Paediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido